These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. Yee LD; Sabourin CL; Liu L; Li HM; Smith PJ; Seewaldt V; Kniss DA Int J Oncol; 1999 Nov; 15(5):967-73. PubMed ID: 10536181 [TBL] [Abstract][Full Text] [Related]
4. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998 [TBL] [Abstract][Full Text] [Related]
5. A regulatory role for RIP140 in nuclear receptor activation. Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662 [TBL] [Abstract][Full Text] [Related]
6. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Tontonoz P; Singer S; Forman BM; Sarraf P; Fletcher JA; Fletcher CD; Brun RP; Mueller E; Altiok S; Oppenheim H; Evans RM; Spiegelman BM Proc Natl Acad Sci U S A; 1997 Jan; 94(1):237-41. PubMed ID: 8990192 [TBL] [Abstract][Full Text] [Related]
7. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Tsibris JC; Porter KB; Jazayeri A; Tzimas G; Nau H; Huang H; Kuparadze K; Porter GW; O'Brien WF; Spellacy WN Cancer Res; 1999 Nov; 59(22):5737-44. PubMed ID: 10582693 [TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612 [TBL] [Abstract][Full Text] [Related]
9. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578 [TBL] [Abstract][Full Text] [Related]
10. Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors. Wahli W; Devchand PR; IJpenberg A; Desvergne B Adv Exp Med Biol; 1999; 447():199-209. PubMed ID: 10086196 [No Abstract] [Full Text] [Related]
11. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Sarraf P; Mueller E; Smith WM; Wright HM; Kum JB; Aaltonen LA; de la Chapelle A; Spiegelman BM; Eng C Mol Cell; 1999 Jun; 3(6):799-804. PubMed ID: 10394368 [TBL] [Abstract][Full Text] [Related]
12. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Girnun GD; Domann FE; Moore SA; Robbins ME Mol Endocrinol; 2002 Dec; 16(12):2793-801. PubMed ID: 12456800 [TBL] [Abstract][Full Text] [Related]
14. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836 [TBL] [Abstract][Full Text] [Related]
15. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558 [TBL] [Abstract][Full Text] [Related]
16. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Dubuquoy L; Dharancy S; Nutten S; Pettersson S; Auwerx J; Desreumaux P Lancet; 2002 Nov; 360(9343):1410-8. PubMed ID: 12424006 [TBL] [Abstract][Full Text] [Related]
17. Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists. Sato M; Yajima Y; Kawashima S; Tanaka K; Kagechika H Biochem Biophys Res Commun; 2001 Jan; 280(3):646-51. PubMed ID: 11162570 [TBL] [Abstract][Full Text] [Related]
18. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571 [TBL] [Abstract][Full Text] [Related]
19. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha. Tanaka N; Hora K; Makishima H; Kamijo Y; Kiyosawa K; Gonzalez FJ; Aoyama T FEBS Lett; 2003 May; 543(1-3):120-4. PubMed ID: 12753917 [TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]